Minerva Neurosciences, Inc. (NERV) Ownership
NERV ownership summary
as of October 18, 2026- Institutions
- 93.2% of shares outstanding
- Insiders
- 3.26% of shares outstanding
- Shares outstanding
- 47.7M
- Float
- 34.3M shares available to trade
- Short interest
- 5.34% 2.4M shares short
- Days to cover
- 15.60 short interest up 0.6% vs prior month
- Institutions 93.18%
- Insiders 3.26%
- Other investors 3.56%
NERV top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Federated Hermes Inc | 9.78% | 4.7M | $11.0M | −442,798 (−8.7%) | June 30, 2026 |
| 2 | Jupiter Topco LLC | 9.19% | 4.4M | $10.3M | +4.4M (0.0%) | June 30, 2026 |
| 3 | Vivo Capital, LLC | 9.05% | 4.3M | $10.2M | — | June 30, 2026 |
| 4 | HHG PLC | 8.99% | 4.3M | $10.1M | +4.3M (+47,614.0%) | March 31, 2026 |
| 5 | Balyasny Asset Management LLC | 8.92% | 4.3M | $10.0M | −1,600 (−0.0%) | June 30, 2026 |
| 6 | Logos Global Management LP | 6.89% | 3.3M | $7.7M | +73,777 (+2.3%) | June 30, 2026 |
| 7 | Farallon Capital Management, L.L.C. | 4.95% | 2.4M | $5.6M | — | June 30, 2026 |
| 8 | BlackRock Inc | 4.69% | 2.2M | $5.3M | +1.6M (+258.6%) | June 30, 2026 |
| 9 | Ally Bridge Group (NY) LLC | 4.56% | 2.2M | $5.1M | +520,302 (+31.4%) | June 30, 2026 |
| 10 | Foresite Capital Management VI LLC | 4.16% | 2.0M | $4.7M | −1,016 (−0.1%) | June 30, 2026 |
| 11 | Vanguard Capital Management, LLC | 3.96% | 1.9M | $4.4M | +46,976 (+2.5%) | June 30, 2026 |
| 12 | Spruce Street Capital LP | 3.47% | 1.7M | $3.9M | — | June 30, 2026 |
| 13 | Trails Edge Capital Partners, LP | 2.97% | 1.4M | $3.3M | — | June 30, 2026 |
| 14 | Adage Capital Partners Gp LLC | 2.97% | 1.4M | $3.3M | — | June 30, 2026 |
| 15 | Seven Fleet Capital Management LP | 2.10% | 1.0M | $2.4M | +752,897 (+303.0%) | June 30, 2026 |
| 16 | Geode Capital Management, LLC | 2.04% | 974K | $2.3M | +635,501 (+187.6%) | June 30, 2026 |
| 17 | DV EQUITIES, LLC | 1.58% | 754K | $1.8M | +754,397 (0.0%) | June 30, 2026 |
| 18 | Longwood Capital Partners LLC | 1.49% | 710K | $1.7M | — | June 30, 2026 |
| 19 | Millennium Management LLC | 1.12% | 534K | $1.3M | −174,689 (−24.7%) | June 30, 2026 |
| 20 | State Street Corp | 0.89% | 425K | $998,550 | +368,566 (+654.1%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 13.4M shares and 4 cut 620K.
NERV top mutual fund and ETF holders
17 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.95% | 1.4M | $3.3M | +87,310 (+6.6%) | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 1.74% | 831K | $2.0M | −9,600 (−1.1%) | September 30, 2026 |
| 3 | Federated Hermes Kaufmann Small Cap A | 1.05% | 502K | $1.2M | −167,066 (−25.0%) | June 30, 2026 |
| 4 | Federated Hermes Kaufmann R | 1.01% | 484K | $1.1M | −267,868 (−35.6%) | June 30, 2026 |
| 5 | Fidelity Small Cap Index | 0.78% | 370K | $870,365 | +2,326 (+0.6%) | July 31, 2026 |
| 6 | Fidelity Extended Market Index | 0.48% | 229K | $537,694 | −1,230 (−0.5%) | August 31, 2026 |
| 7 | iShares Russell 2000 Growth ETF | 0.47% | 222K | $522,022 | −281 (−0.1%) | September 30, 2026 |
| 8 | Vanguard Russell 2000 ETF | 0.44% | 209K | $492,118 | +13,057 (+6.6%) | September 30, 2026 |
| 9 | iShares Micro-Cap ETF | 0.24% | 115K | $271,246 | −796 (−0.7%) | September 30, 2026 |
| 10 | iShares Russell 2000 Value ETF | 0.20% | 93K | $218,980 | +142 (+0.2%) | September 30, 2026 |
| 11 | Fidelity Total Market Index | 0.18% | 85K | $199,228 | +3,821 (+4.7%) | August 31, 2026 |
| 12 | Schwab Small Cap Index | 0.17% | 83K | $194,169 | — | August 31, 2026 |
| 13 | Fidelity Series Total Market Index | 0.15% | 71K | $166,420 | — | August 31, 2026 |
| 14 | iShares Russell 2000 Small-Cap Idx Instl | 0.13% | 64K | $149,570 | — | August 31, 2026 |
| 15 | Nuveen Small Cap Blend Idx R6 | 0.10% | 45K | $106,873 | — | August 31, 2026 |
| 16 | EQ/2000 Managed Volatility IB | 0.07% | 34K | $80,624 | — | August 31, 2026 |
| 17 | Schwab Total Stock Market Index | 0.06% | 31K | $72,850 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NERV insider transactions
latest 3| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-01 | Frederick W Ahlholm | Sell | $4.48 | 3,580 | $16,038 |
| 2023-05-01 | Geoff Race | Sell | $3.85 | 22,082 | $85,016 |
| 2023-05-01 | Remy Luthringer | Sell | $3.85 | 23,753 | $91,449 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
NERV shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NERV
Institutional investors own 93.2% of Minerva Neurosciences's shares and insiders 3.26%. The largest holder is Federated Hermes Inc with 9.78% of the shares (4.7M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 4 reduced their stake in the latest filings. Short interest is 5.34% of the float, or 15.60 days of average trading volume. The share count rose 358.1% since 2014.
Related: NERV analyst forecast, NERV key metrics. See the NERV stock overview for the latest quote and news.
NERV ownership FAQ
Who owns the most Minerva Neurosciences stock?
The largest shareholders of Minerva Neurosciences are Federated Hermes Inc (9.78%), Jupiter Topco LLC (9.19%), Vivo Capital, LLC (9.05%), HHG PLC (8.99%), Balyasny Asset Management LLC (8.92%).
What percentage of Minerva Neurosciences is owned by institutions?
Institutions hold 93.2% of Minerva Neurosciences's shares outstanding; insiders hold 3.26%.
Which funds own Minerva Neurosciences?
The largest fund holders of Minerva Neurosciences are Vanguard MStar Total Stk Mkt Idx Invest (2.95%), iShares Russell 2000 ETF (1.74%), Federated Hermes Kaufmann Small Cap A (1.05%), Federated Hermes Kaufmann R (1.01%), Fidelity Small Cap Index (0.78%).
What is Minerva Neurosciences's short interest?
2.4M shares of Minerva Neurosciences were sold short, 5.34% of the float; at the average daily volume it would take 15.60 days to cover.
Are insiders buying or selling Minerva Neurosciences?
Of the latest 3 reported insider transactions in Minerva Neurosciences (since May 1, 2023), 0 were purchases and 3 were sales.
How many shares of Minerva Neurosciences are outstanding?
Minerva Neurosciences has 47.7M shares outstanding, of which 34.3M are in the public float.